Kura Oncology, Inc. (KURA)

Kura Oncology Revenue

In the year 2025, Kura Oncology had annual revenue of $67.48M with 25.24% growth. Kura Oncology had revenue of $17.34M in the quarter ending December 31, 2025, a decrease of -67.83%.

• Revenue (ttm): $67.48M
• Revenue Growth: +25.24%
• P/S Ratio: 10.46
• Revenue / Employee: $259,546
• Employees: 260
• Market Cap: 712.82M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.48M	13.60M	25.24%
Dec 31, 2024	53.88M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-